14 citations
,
January 2017 in “Elsevier eBooks” This review explores cannabigerol (CBG) as a potential therapeutic agent with various pharmacological activities but reports no new clinical results, emphasizing the need for further research on its efficacy and safety.
June 2023 in “Journal of Education, Health and Sport” This study reviewed existing evidence and concluded that while CBD is an effective treatment for certain epilepsy syndromes, more research is required to establish its safety and effectiveness for conditions like anxiety and Parkinson’s disease, and clinicians should monitor ongoing trial results.
March 2024 in “International Research Journal Of Modernization In Engineering Technology And Science” This review highlights the beneficial effects of certain herbal drugs in treating skin diseases, such as their healing, antifungal, antiviral, antibacterial, anti-inflammatory, and antitumor-promoting activities, emphasizing recent technical advancements in the field over the past 17 years.
6 citations
,
June 2023 in “American Society of Clinical Oncology Educational Book” This review highlights emerging strategies to manage chemotherapy side effects like nausea, neuropathy, and alopecia, noting that scalp cooling has been effective for reducing hair loss, while cryotherapy and cannabis show promise but need further study for side effect management.
14 citations
,
September 2023 in “The Medical Journal of Australia” The researchers reported a rapid expansion of direct-to-consumer telemedicine services in Australia since the COVID-19 pandemic, driven by substantial investment and changes in telehealth regulations.